News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
XV Meet-URO Meeting Concludes After Two Days of Scientific Exchange
Meet-URO/X
May 17, 2025, 19:44

XV Meet-URO Meeting Concludes After Two Days of Scientific Exchange

Meet-URO shared on X:

“The XV Meet-URO Meeting ended today. Two days of discussion, research and new connections.
Thanks to all the participants. Onward, with even more motivation!”

The 15th edition of the Meet-URO Meeting brought together experts in urologic oncology for two days of dynamic discussions, scientific presentations, and networking—fostering collaboration and momentum for future research.

See more posts related to Urologic Oncology on OncoDaily.

cancer OncoDaily Oncology urologic oncology XV Meet-URO Meeting
Special Coverage
Blog
May 17, 2025, 19:44
XV Meet-URO Meeting Concludes After Two Days of Scientific Exchange
Blog
May 17, 2025, 19:16
Nikos Papandreou Outlines His Bold Vision for a More Equitable and Innovation-Driven Approach to Cancer Care in CancerWorld Interview
Science
May 17, 2025, 17:38
Chiara Corti: Decoding Clinical Trials in Metastatic Breast Cancer - Practical Insights for Optimal Therapy Sequencing
Blog
May 17, 2025, 17:27
Raffaella Casolino: Attending the 1st Cancer Planners Forum was One of the Most Incredible Experiences of my Career
Blog
May 17, 2025, 17:21
Paolo Tarantino Highlights Real-World Data on ADC Sequencing in Breast Cancer
Blog
May 17, 2025, 16:10
Aruni Ghose Shared Survey on Cancer Patient Engagement and MDT Awareness
Blog
May 17, 2025, 15:37
Mark Lawler Launches Report on Data-Driven Cancer Innovation in Ireland
Blog
May 17, 2025, 15:36
Rasha Aboelhassan: Should we Give Chemotherapy with Immunotherapy as a Neoadjuvant Setting in stage I TNBC?
Blog
May 17, 2025, 15:28
Yakup Ergün: Great Debate on Continuing CDK4/6 After Progression
Oncolibrary
May 17, 2025, 15:23
SGNTUC-019 Trial Final Results: Tucatinib + Trastuzumab Shows Durable Benefit in HER2-Mutant MBC at ESMO 2025
Blog
May 17, 2025, 15:22
Danielle Bitterman: Generating Evidence, Engaging Patients, and Investing in Trust Will Get us Where we Need to Go
Blog
May 17, 2025, 15:15
Jason Efstathiou: Looking Forward to PTCOG 2025 Next Month